Institutional investors purchased a net $2.9 million shares of NSPH during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 22.28% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Mutual fund holders | 8.35% |
| Individual stakeholders | 37.66% |
| Other institutional | 13.93% |